Lung cancer is the most prevalent, rapidly spreading, and highly invasive, malignancy that kills many people. Diethyl nitrosamine (DEN) is a well-known carcinogen that causes cancer in a variety of organs in rats. Aim: The aim of the study was to investigate therapeutic applications of biogenic silver nanoparticles (AgNPs) as well as the detrimental effects of DEN on the regulation of TLR4, ERK1/2, and PI3K expression in lung tissues of male rats. A total of twenty rats (weight 150-250 grams) were randomly assigned to four experimental groups: Control, DEN-treated (90 mg/kg, intraperitoneally), DEN+AgNPs, and AgNPs alone (100 mg/kg, administered orally). After five weeks, the rats were dissected, and the blood samples were collected for complete blood count (CBC) analysis. Lung tissues were fixed in 10% buffered formalin for histopathological examination. Frozen lung tissues were used to extract DNA for the DNA ladder assay. Additionally, western blotting was performed to assess the expression levels of TLR4, ERK1/2, and PI3K. A significant reduction was observed in body weight of rats due to DEN treatment which was overcame with AgNPs treatment. Furthermore, in comparison to the control group, there was significant increase in MCV and MCH in the DEN group, Hb, MCV, and MCH in the DEN+AgNPs group, and Hb and MCV in the AgNPs group. Moreover, lung tissues of DEN-treated animals showed a modest proliferation of alveolar cells compared to control group. Genomic DNA isolated from the lung tissues of DEN treated animals showed smear, however, genomic DNA isolated from AgNPs treated groups was found normal. Down regulation of TLR4 and upregulation of ERK1/2 and PI3K was found in DEN-treated rats. Treatment with AgNPs reversed the expression of TLR4, ERK1/2, and PI3K. Altogether, these results showed that AgNPs have therapeutic potential against DEN-induced toxicity in a male rat model.